Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Myriad Genetics (MYGN) Leases (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Leases for 16 consecutive years, with $49.4 million as the latest value for Q4 2025.

  • Quarterly Leases fell 10.18% to $49.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.4 million through Dec 2025, down 10.18% year-over-year, with the annual reading at $49.4 million for FY2025, 10.18% down from the prior year.
  • Leases for Q4 2025 was $49.4 million at Myriad Genetics, down from $50.6 million in the prior quarter.
  • The five-year high for Leases was $110.6 million in Q3 2022, with the low at $5.9 million in Q1 2023.
  • Average Leases over 5 years is $59.5 million, with a median of $58.2 million recorded in 2021.
  • The sharpest move saw Leases plummeted 94.67% in 2023, then soared 898.31% in 2024.
  • Over 5 years, Leases stood at $81.8 million in 2021, then rose by 27.02% to $103.9 million in 2022, then plummeted by 40.71% to $61.6 million in 2023, then fell by 10.71% to $55.0 million in 2024, then decreased by 10.18% to $49.4 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $49.4 million, $50.6 million, and $51.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.